Co‑Innovation Programme with Singapore
A unique opportunity for Singapore-based startups to co-develop innovative health-tech solutions with Charité – Universitätsmedizin Berlin / BIH researchers. Funding, clinical expertise, and international collaboration await.
🔍 Quick Snapshot
- Provider: Charité – Universitätsmedizin Berlin, BIH & Enterprise Singapore
- Opportunity Type: Co-Development & Matched-Funding Partnership
- Programme Phase: Second Call (2025–2026)
- EOI Deadline: 15 August 2025
- Full Proposal Deadline: 31 January 2026
- Start Date: April 2026
- Eligibility: Singapore-Registered Startups
🌍 About the Programme
The Co‑Innovation Programme links Singapore startups with leading clinical researchers at Charité – Universitätsmedizin Berlin and the Berlin Institute of Health (BIH). With support from Enterprise Singapore, this initiative funds translational collaborations focused on real-world healthcare applications—spanning prototyping, pilot studies, and joint development phases.
✅ Eligibility Criteria
- Registered startup headquartered in Singapore
- Health-tech or biomedical innovation with clinical application
- Paired collaboration with a researcher from Charité/BIH
- EOI submission by 15 August 2025
- Full proposal co-developed with clinical partner by 31 January 2026
- 50% project co-funding commitment by the startup
🎁 Programme Benefits
- Matched funding from Enterprise Singapore
- Access to Charité/BIH’s clinical infrastructure & expertise
- Joint product development or pilot validation opportunities
- Strategic market readiness support
- Cross-border innovation and visibility in EU/Germany
📝 How to Apply
- Visit the official BIH Co‑Innovation Programme Page
- Submit an Expression of Interest (EOI) to Enterprise Singapore by 15 August 2025
- If shortlisted, get matched with a Charité/BIH researcher and sign a Letter of Intent
- Collaboratively develop a full project proposal with your partner
- Submit the full application by 31 January 2026
- Await funding decision and begin contracting from March 2026
📅 Program Timeline
- EOI Deadline: 15 August 2025
- Full Proposal Submission: 31 January 2026
- Funding Decisions: From March 2026
- Project Start: April 2026
🤝 Ready to Collaborate Globally?
Apply now for the Charité–Enterprise Singapore Co‑Innovation Programme and bring your health-tech solution to Europe’s clinical frontline.
View Programme DetailsQuestions? Contact info@bihealth.de or your Enterprise Singapore officer
Curated by Growth Forum Malaysia — fostering global innovation partnerships in health and technology.
Source: bihealth.org
📬 Join the Growth Forum Circle
Be the first to know about game-changing opportunities, exclusive funding alerts, and curated insights from changemakers across ASEAN.
✨ Sign Me Up NowNo spam. Just real updates. Unsubscribe anytime.
